Postdoctoral researcher Isidro Arévalo Vargas at the Spanish Foundation for the Study and Therapy of Gaucher Disease and Other Lysosomal Disorders discusses multiomics analysis, dried blood spot testi...

Background: Ovarian cancer remains one of the most lethal gynecologic malignancies, largely due to pronounced molecular heterogeneity, nonspecific clinical presentation, and frequent diagnosis at advanced stages. Multiomics profiling—including genomics, transcriptomics, and epigenomics—offers a powerful avenue for characterizing this complexity and enabling more precise patient stratification. Objective: This study aimed to address key challenges in multiomics analysis, including high dimensionality, cross-modality heterogeneity, limited sample size, and the lack of effective approaches for survival stratification of patients with ovarian cancer through deep representation learning. Methods: We analyzed multiomics data from The Cancer Genome Atlas and developed a 5-stage deep learning pipeline centered on variational autoencoders (VAEs) for nonlinear dimensionality reduction and latent representation learning. A graph convolutional neural network component is described as a proposed extension for modeling interaction-aware representations but was not empirically evaluated in this study. Latent embeddings derived from the VAE were clustered using k-means, and their prognostic relevance was assessed using Cox proportional hazards modeling and Kaplan-Meier survival analysis. Results: Following correction of a clinical-molecular harmonization issue, the final matched cohort comprised 291 patients. Silhouette analysis identified k=2 as the optimal clustering solution (silhouette=0.272). Kaplan-Meier analysis demonstrated significantly different overall survival between the two clusters (log-rank =10.0; =.002). Cox proportional hazards modeling estimated a hazard ratio of 0.519 (95% CI 0.343‐0.785; =.002), indicating that patients assigned to cluster 1 exhibited an approximately 48% lower hazard of death than those in cluster 0. These results demonstrate that the learned latent representations capture prognostically relevant structure within the integrated multiomics data. Conclusions: The proposed VAE-based framework identified 2 prognostically distinct patient subgroups with significantly different overall survival. These findings demonstrate the potential of deep generative representation learning for multiomics-based survival stratification in ovarian cancer and provide a foundation for future validation in independent cohorts and the evaluation of graph-based extensions.

Bruker CosMx and how it compares to 10X Genomics Xenium

A multiomics approach reveals immune dysregulation signatures that characterize the clinical phenotypes of human RAG deficiency.

Tissue expansion mass spectrometry imaging enables the mapping of lipids, metabolites, proteins, peptides and N-glycans at high spatial resolution.

Illumina announced two hours ago that they have a new spatial technology program aiming at mapping complex tissues and understand cellular behaviour at a high-throughput scale.

Nature Communications - How non-coding mutations in DNA contribute to phenotypes is a largely unresolved question. Here the authors integrate personal genomics and machine learning to identify...

Nature Protocols - CellPhoneDB combines a curated database of receptor–ligand interactions with methods to infer cell–cell communication from single-cell expression data. This protocol...

Multiomic phenotyping provides molecular insights into complex physiological processes and pathologies. The study uses 18 omics platforms to analyze biofluids from 391 participants. It constructs a co...

Single-cell and spatial multiomics analyses identify breakout lesions as a hotspot for tumor-immune interactions and diversification.